Product
E2/NETA
1 clinical trial
2 indications
Indication
Heavy menstrual bleedingIndication
Uterine FibroidsClinical trial
A Phase 3b Study to Evaluate the Long-Term Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenStatus: Active (not recruiting), Estimated PCD: 2024-07-11